IRESSA for advanced non-small cell lung cancer treatment with an EGFR-TK (epidermal growth factor receptor-tyrosine kinase) inhibitor. Site provides relevant lung cancer information for oncology research to health care professionals and patients.
(Added:
31-Jan-2005
| Hits:
0
| Rating:
0
| Votes:
0
) Info |
Rate It